SHAH ALAM, 18 May 2026 – Pharmaniaga Berhad carried its recovery momentum into financial year 2026, reporting profit after tax of RM32.2 million for the first quarter ended 31 March 2026, supported by stronger revenue, higher Government hospital order volumes and lower finance costs.
The Q1FY2026 performance marked Pharmaniaga’s ninth consecutive profitable quarter since Q1FY2024, reinforcing the Group’s improving fundamentals after a period of regularisation. Profit after tax rose 6.4% from RM30.2 million in the corresponding quarter last year, while profit before zakat and taxation increased to RM46.4 million from RM45.5 million previously.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here
